BIGG

2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

Ann. rheum. dis; 82 (6), 2023

To develop EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases (AIIRD). An international Task Force (TF) (22 members/15 countries) formulated recommendations, supported by systematic literature review find...

Prevención de Enfermedades, Infecciones Oportunistas/etiología, Enfermedades Autoinmunes/complicaciones, Enfermedades Reumáticas/complicaciones, Triaje/normas, Tuberculosis/prevención & control, Hepatitis B/prevención & control, Hepatitis C/prevención & control, Herpesvirus Humano 3, Pneumocystis carinii/inmunología, Profilaxis Posexposición, Antivirales/uso terapéutico

Texto completo

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

World Health Organization.

These guidelines provide guidance on the diagnosis of HIV infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 201...

Infecciones por VIH/tratamiento farmacológico, Fármacos Anti-VIH/uso terapéutico, VIH/efectos de los fármacos, Infecciones por VIH/prevención & control, Profilaxis Pre-Exposición, Profilaxis Posexposición, Antirretrovirales/administración & dosificación

Texto completo (enlace principal) Texto completo (enlace alternativo)

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV

World Health Organization.

Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or ...

Antirretrovirales/administración & dosificación, Infecciones por VIH/tratamiento farmacológico, Infecciones por VIH/prevención & control, Profilaxis Posexposición, Diagnóstico Precoz

Texto completo

Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups

World Health Organization.

This guideline provides global, evidence-informed recommendations on preventive chemotherapy (deworming), as a public health intervention in areas endemic for soil-transmitted helminths, to decrease the worm burden of soil-transmitted helminth infections in children, adolescent girls, women of reproducti...

Mebendazol/administración & dosificación, Enfermedades Desatendidas/prevención & control, Antihelmínticos/administración & dosificación, Grupos de Riesgo, Albendazol/administración & dosificación, Profilaxis Posexposición, Helmintiasis/prevención & control, Suelo/parasitología

Texto completo (enlace principal) Texto completo (enlace alternativo)

Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

World Health Organization.

In this second supplement (December 2014) to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, recommendations from two guideline development processes are included: post-exposure prophylaxis for HIV; the use of co-trimoxazole prophylaxis for H...

Infecciones por VIH/prevención & control, Profilaxis Posexposición/métodos, Poblaciones Vulnerables, Antiinfecciosos/administración & dosificación, Combinación Trimetoprim y Sulfametoxazol/administración & dosificación, Antirretrovirales/administración & dosificación, Infecciones Oportunistas Relacionadas con el SIDA/prevención & control, Factores de Riesgo, Infecciones por VIH/tratamiento farmacológico

Texto completo (enlace principal) Texto completo (enlace alternativo)